Assetmark, Inc Icon PLC Transaction History

Assetmark, Inc

$36.4 Billion
Q4 2024

A detailed history of Assetmark, Inc transactions in Icon PLC stock. As of the latest transaction made, Assetmark, Inc holds 872 shares of ICLR stock, worth $171,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares

872

Previous 903 3.43%

Holding current value

$171,086

Previous $259,000 29.73%

% of portfolio

0.0%

Previous 0.0%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$187.22 - $297.57 $5,803 - $9,224	-31 Reduced 3.43%	872 $182,000
Q3 2024 Nov 01, 2024	BUY	$280.48 - $346.2 $37,303 - $46,044	133 Added 17.27%	903 $259,000
Q2 2024 Aug 13, 2024	BUY	$288.23 - $331.73 $3,746 - $4,312	13 Added 1.72%	770 $241,000
Q1 2024 May 06, 2024	SELL	$247.84 - $340.0 $50,559 - $69,360	-204 Reduced 21.23%	757 $254,000
Q4 2023 Feb 09, 2024	BUY	$222.83 - $285.76 $67,740 - $86,871	304 Added 46.27%	961 $272,000
Q3 2023 Oct 27, 2023	SELL	$236.44 - $265.62 $307,844 - $345,837	-1,302 Reduced 66.46%	657 $161,000
Q2 2023 Aug 11, 2023	BUY	$183.12 - $250.2 $81,488 - $111,339	445 Added 29.39%	1,959 $490,000
Q1 2023 May 05, 2023	BUY	$193.59 - $245.33 $58,270 - $73,844	301 Added 24.81%	1,514 $323,000
Q4 2022 Feb 10, 2023	BUY	$173.9 - $224.8 $67,125 - $86,772	386 Added 46.67%	1,213 $235,000
Q3 2022 Nov 01, 2022	BUY	$183.25 - $247.5 $64,137 - $86,625	350 Added 73.38%	827 $152,000
Q2 2022 Aug 03, 2022	BUY	$197.3 - $261.32 $60,176 - $79,702	305 Added 177.33%	477 $103,000
Q1 2022 May 13, 2022	BUY	$216.09 - $296.03 $19,448 - $26,642	90 Added 109.76%	172 $42,000
Q4 2021 Feb 14, 2022	SELL	$258.11 - $309.7 $3,613 - $4,335	-14 Reduced 14.58%	82 $25,000
Q3 2021 Nov 12, 2021	BUY	$208.53 - $283.04 $2,502 - $3,396	12 Added 14.29%	96 $25,000
Q2 2021 Aug 16, 2021	BUY	$194.07 - $232.2 $11,838 - $14,164	61 Added 265.22%	84 $17,000
Q1 2021 May 14, 2021	SELL	$171.87 - $220.96 $33,170 - $42,645	-193 Reduced 89.35%	23 $5,000
Q4 2020 Feb 10, 2021	BUY	$180.3 - $214.08 $7,933 - $9,419	44 Added 25.58%	216 $42,000
Q3 2020 Nov 13, 2020	BUY	$166.91 - $196.1 $23,701 - $27,846	142 Added 473.33%	172 $33,000
Q2 2020 Aug 11, 2020	SELL	$129.79 - $170.94 $20,377 - $26,837	-157 Reduced 83.96%	30 $5,000
Q1 2020 May 12, 2020	SELL	$115.95 - $177.22 $70,613 - $107,926	-609 Reduced 76.51%	187 $25,000
Q4 2019 Feb 11, 2020	BUY	$139.48 - $172.23 $42,959 - $53,046	308 Added 63.11%	796 $137,000
Q3 2019 Nov 13, 2019	BUY	$146.89 - $161.41 $6,463 - $7,102	44 Added 9.91%	488 $72,000
Q2 2019 Aug 14, 2019	SELL	$129.99 - $153.97 $2,079 - $2,463	-16 Reduced 3.48%	444 $68,000
Q1 2019 May 14, 2019	SELL	$121.3 - $146.95 $1,091 - $1,322	-9 Reduced 1.92%	460 $63,000
Q4 2018 Feb 13, 2019	BUY	$119.37 - $153.29 $596 - $766	5 Added 1.08%	469 $61,000
Q3 2018 Nov 13, 2018	BUY	$131.3 - $153.75 $1,575 - $1,845	12 Added 2.65%	464 $71,000
Q2 2018 Aug 01, 2018	BUY	$111.38 - $137.03 $1,113 - $1,370	10 Added 2.26%	452 $60,000
Q1 2018 May 16, 2018	SELL	$103.82 - $123.9 $43,915 - $52,409	-423 Reduced 48.9%	442 $52,000
Q4 2017 Feb 13, 2018	BUY	$111.14 - $123.05 $15,115 - $16,734	136 Added 18.66%	865 $97,000
Q3 2017 Nov 08, 2017	SELL	$101.4 - $116.62 $1,216 - $1,399	-12 Reduced 1.62%	729 $83,000
Q2 2017 Aug 15, 2017	BUY	N/A	207 Added 38.76%	741 $72,000
Q1 2017 Sep 15, 2017	SELL	N/A	-223 Reduced 29.46%	534 $43,000
Q4 2016 Sep 15, 2017	SELL	N/A	-62 Reduced 7.57%	757 $57,000
Q3 2016 Sep 15, 2017	SELL	N/A	-39,941 Reduced 97.99%	819 $63,000
Q2 2016 Sep 15, 2017	SELL	N/A	-2,539 Reduced 5.86%	40,760 $2.85 Million
Q1 2016 Sep 15, 2017	BUY	N/A	25,489 Added 143.12%	43,299 $3.25 Million
Q4 2015 Sep 15, 2017	BUY	N/A	17,810	17,810 $1.38 Million

Others Institutions Holding ICLR

# of Institutions

641

Shares Held

76.8M

Call Options Held

152K

Put Options Held

447K

View Full List

About ICON PLC

Ticker ICLR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 81,526,600
Market Cap $16B
Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...

More about ICLR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account